Your Advocates Ltd., LLP Oncorus, Inc. Transaction History

Your Advocates Ltd., LLP

  • $180 Million
  • Q2 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 29, 2021
BUY
$13.3 - $17.3 $1,330 - $1,730
100 New
100 $1,000

About Oncorus, Inc.

ONCR Quotes by TradingView
  • Ticker ONCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,973,100
  • Description
  • Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various canc...
More about ONCR
Track This Portfolio

Track Your Advocates Ltd., LLP Portfolio

Follow Your Advocates Ltd., LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Your Advocates Ltd., LLP, based on Form 13F filings with the SEC.

News

Stay updated on Your Advocates Ltd., LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email